Active ingredientOctreotideCat. No. P-O009-001CAS 83150-76-9Family · Pharmaceutical analytical standards
Octreotide
A synthetic analogue of somatostatin made of eight amino acids, first prepared in 1979 by chemist Wilfried Bauer and approved in the United States in 1988: it is used for acromegaly, carcinoid syndrome and bleeding from oesophageal varices. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Bound to radioactive indium-111 it becomes a tracer for scintigraphy that makes tumours rich in somatostatin receptors visible.
Go to the active ingredient →Active ingredientOctreotideCat. No. P-O009-001CAS 83150-76-9
Active ingredientOctreotide AcetateCat. No. P-O009-002CAS 79517-01-4
Pharmacopoeial impurityOctreotide EP Impurity CCat. No. P-O009-004CAS 1546983-16-7
Pharmacopoeial impurityOctreotide EP Impurity ICat. No. P-O009-005CAS 83795-61-3
Impurity(Des-Thr-Ol8)-Octreotide (TFA Salt)Cat. No. P-O009-008CAS 160841-00-9![[O1(Ac)]8-Octreotide (Acetate Salt)](https://img.vitasanlabs.com/vsl-struct/P-O009-009.svg?v=41e934f030)
Impurity[O1(Ac)]8-Octreotide (Acetate Salt)Cat. No. P-O009-009CAS 133304-81-1
ImpurityDiglycolyl-Threoninyl OctreotideCat. No. P-O009-011
Pharmacopoeial impurityOctreotide EP Impurity H (Acetate Salt)Cat. No. P-O009-012CAS 173606-11-6
ImpurityOctreotide Impurity 1Cat. No. P-O009-016CAS 1546983-33-8
ImpurityOctreotide Impurity 2Cat. No. P-O009-017CAS 1546983-18-9
ImpurityOctreotide Non-Cyclic System Suitability Marker TFA SaltCat. No. P-O009-019No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceOctreotide CRSEDQM code Y0002104Family OctreotideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.